New data from Reach2HD trial presented at American Neurological Association Annual Meeting October 18, 2016
First volunteers dosed in Phase I clinical trial of PBT434, Prana’s lead therapy for parkinsonian diseases July 3, 2018
Prana to Present at the B. Riley FBR China Healthcare Investment & Partnering Symposium in Hangzhou, China March 15, 2018
